These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6024655)

  • 1. Current programs of national surveillance, including evaluation of vaccines in industrial populations.
    Dull HB
    Arch Environ Health; 1967 May; 14(5):739-46. PubMed ID: 6024655
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute respiratory infections in civilian adults. I. Antibody response to polyvalent influenza--adenovirus inactivated vaccine.
    COX F; TIMM EA; QUINN EL; COLVILLE JM; McLEAN IW
    Henry Ford Hosp Med Bull; 1962 Mar; 10():27-33. PubMed ID: 13881896
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Hobson D; Baker FA; Curry RL; Beare AS; Massey PM
    J Hyg (Lond); 1973 Dec; 71(4):641-7. PubMed ID: 4588772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community interventions and the epidemic prevention potential.
    Halloran ME; Longini IM; Cowart DM; Nizam A
    Vaccine; 2002 Sep; 20(27-28):3254-62. PubMed ID: 12213394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON.
    HOWELL RW; STOTT AN
    Br J Ind Med; 1964 Oct; 21(4):259-64. PubMed ID: 14249893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of acute viral respiratory diseases. Effects of infection, vaccines, and chemotherapy.
    Jackson GG
    Arch Environ Health; 1967 May; 14(5):759-67. PubMed ID: 4290424
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization of selected population groups against influenza. The rationale of current recommendations.
    Francis T
    Arch Environ Health; 1967 May; 14(5):747-8. PubMed ID: 6024656
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surveillance of influenza and its prophylaxis].
    Brydak LB
    Pol Arch Med Wewn; 2001; 105 Suppl():321-8. PubMed ID: 12412263
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness.
    Ansaldi F; De Florentiis D; Parodi V; Rappazzo E; Coppelli M; Martini M; Alicino C; Durando P; Icardi G
    J Prev Med Hyg; 2012 Jun; 53(2):94-7. PubMed ID: 23240167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccines: the good, the bad, and the eggs.
    Schultz-Cherry S; Jones JC
    Adv Virus Res; 2010; 77():63-84. PubMed ID: 20951870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on influenza vaccine in industry.
    Smith JW; Pollard R
    Postgrad Med J; 1973 Mar; 49(569):169-74. PubMed ID: 4802598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute respiratory infection morbidity after the use of killed influenza A/Victoria/72 vaccine].
    Ivanov KG; Beliakov VD; Ishkil'din MI; Maliarenko IuD
    Tr Inst Im Pastera; 1976; 47():146-50. PubMed ID: 802565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Work experience in epidemiologic monitoring of influenza and ARD in Rovno Province].
    Reznikov AP; Muliar IS; Sapego ZhK
    Vrach Delo; 1989 Dec; (12):104-6. PubMed ID: 2629264
    [No Abstract]   [Full Text] [Related]  

  • 14. Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha.
    Tyrrell DA; Peto M; King N
    J Hyg (Lond); 1967 Sep; 65(3):327-41. PubMed ID: 4293359
    [No Abstract]   [Full Text] [Related]  

  • 15. [Various forms of respiratory viral diseases among children in Leningrad].
    Kaplan AS; Andreeva TV; Stupa VG
    Vopr Virusol; 1969; 14(5):607-11. PubMed ID: 4334576
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS; Hierholzer JC
    Am J Epidemiol; 1970 Oct; 92(4):248-56. PubMed ID: 5458217
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of purified and conventional inactivated influenza virus vaccines.
    Mogabgab WJ
    Bull World Health Organ; 1969; 41(3):557-61. PubMed ID: 5309475
    [No Abstract]   [Full Text] [Related]  

  • 18. Surveillance of influenza and other respiratory infections.
    Commun Dis Rep CDR Wkly; 2000 Nov; 10(46):409, 412. PubMed ID: 11116587
    [No Abstract]   [Full Text] [Related]  

  • 19. Update: influenza activity--United States, 2004-05 season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jan; 54(1):14-6. PubMed ID: 15647727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some complications of anti-influenza vaccination in a closed community of infants].
    Bărbuţă R; Ivan A; Dragomir C; Trantea E
    Microbiol Parazitol Epidemiol (Bucur); 1973; 18(5):431-5. PubMed ID: 4767728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.